The objective of this research is to determine the clinical benefits of an innovative and lightweight powered leg controlled using our intent recognition framework in laboratory and community environments.
The hypothesis of this study is that using the Hybrid Leg with seamless, automatic transitions will result in participants choosing to become more active and improve their community participation compared to when using their own passive prosthetic leg. The Hybrid Leg is an an innovative and lightweight powered leg that has 2 operating modes: active and passive. When in active mode, the Hybrid Leg is capable of supplying 120 NM of knee torque and actively repositioning the ankle during non-weight bearing phases of gait. When in passive mode, the motor and transmission are decoupled from the knee, which then behaves like an Ottobock 3R95 passive prosthetic knee, and the non-backdriveable mechanism of the ankle allows it to behave as an energy return foot. Allowing the device to behave passively if the battery becomes depleted or the actuators become damaged is an important enabling safety factor that will allow us to complete our study. Phase 1: We will enroll 20 subjects a clinical trial of the leg and control system who will be fit with the Hybrid Leg and receive in-lab therapy to learn how to ambulate with the device. Phase 2: Subjects will be randomized into a clinical trial of the leg and control system with an AB-BA design; condition A - subjects own device; condition B - Hybrid Leg. Subjects will complete an extensive ambulation and community mobility training to learn optimal use of their own passive device or the Hybrid Leg. After training the subjects will complete a full biomechanical analysis for each device as they complete ambulation circuits that include standing, level-ground walking, walking on slopes and on stairs, sit-stand transitions and transitions between these activities. Phase 3: After completing phase 2 subjects will complete 4-week trials using their assigned prosthesis (Condition A or B) at home and within their community. During the trials subjects will be monitored using mobile phone based sensors and socket mounted activity monitor to determine how often the user performs the ambulation activities.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
20
The Hybrid Knee uses an actively variable transmission in combination of a passive spring/damper system. This allows the motor torque output to be adapted to the requirements of active dynamic tasks - changing the effective transmission ration from zero (fully passive) for level ground walking to a maximum value (fully active) for sit-to-stand transfers. This provides physiological knee torque and speed with a small motor and primary transmission system while also maximizing electrical efficiency, which minimized battery weight. The knee prototype weights 1.7kg. The Semi-active ankle can actively reposition during non-weight bearing phases of gait and uses a non back driveable transmission to maintain its set point during weight bearing activities.
Participants will participate in training sessions of community skills and advanced ambulation training for their home, prescribed passive prosthesis.
Shirley Ryan AbilityLab
Chicago, Illinois, United States
RECRUITINGAverage daily number of steps
This outcome will be assessed using an accelerometery data measured using a mobile phone during the entire 4-week home trial of each device (Hybrid Leg and prescribed home device), resulting in a pair of outcomes for each subject. Statistical analysis will be done , first using a paired t-test (which assumes no carry-over and no device sequence effects), followed by the analysis using a linear mixed model with device and sequence group as fixed effects, and subject as the random effect. We expect that sequence will not be a statistically significant predictor, but that average daily steps will be significantly different between devices, with subjects taking significantly more steps when using the Hybrid Leg.
Time frame: 4 weeks - data collected during 4 week home trial of each device, analyzed upon completion of 4 week home trial
Average daily number of times subject switches between activities
This outcome will be assessed using an accelerometery data measured using a mobile phone during the entire 4-week home trial of each device (Hybrid Leg and prescribed home device), resulting in a pair of outcomes for each subject. Statistical analysis will be done , first using a paired t-test (which assumes no carry-over and no device sequence effects), followed by the analysis using a linear mixed model with device and sequence group as fixed effects, and subject as the random effect. We expect that sequence will not be a statistically significant predictor, but that average transitions will be significantly different between devices, with subjects taking significantly more transitioning between activities more when using the Hybrid Leg.
Time frame: 4 weeks - data collected during 4 week home trial of each device, analyzed upon completion of 4 week home trial
10 Meter Walk Test
The 10mWT is used to assess walking speed in meters/second (m/s) over a short distance.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
GPS tracking analysis
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Subject-specific map of movement within the community will be generated and investigated for individual changes in community mobility and cross-referenced with their survey results. These data could provide insight into how well patient-reported measures reflect actual community participation, although this possibility is acknowledged to be exploratory
Time frame: End of each 4 week home trial
Six-Minute Walk Test
The 6MWT is a sub-maximal exercise test used to assess walking endurance and aerobic capacity. Participants will walk around the perimeter of a set circuit for a total of six minutes.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
Hill Assessment Index
The Hill Assessment Index (HAI) is a 12 level ordinal scale developed to address different characteristics of hill ascent and descent in preparation comparing different prosthetic knee units. The HAI assesses gait patterns on hills combined with assistive device usage reflecting the quality of independence.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
Stair Assessment Index
The Stair Assessment Index is a 14 level ordinal scale that assesses the functional ability of transfemoral amputees for stair ascent and descent. It is being used as a physical measurement tool to document different gait styles on the stairs.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
Berg Balance Scale
The Berg Balance Scale is a 14 item objective measure that assesses static balance and fall risk in adults.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
Functional Gait Assessment
The FGA is used to assess postural stability during walking and assesses an individual's ability to perform multiple motor tasks while walking. The tool is a modification of the 8-item Dynamic Gait Index, developed to improve reliability and reduce ceiling effect.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
5 Times Sit to Stand
The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method of quantify functional lower extremity strength and /or identify movement strategies a patient used to complete transitional movements.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
4 -Square Step Test
Test of dynamic balance that clinically assesses the person's ability to step over objects forward, sideways, and backwards.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device
Amputee Mobility Predictor
This instrument measures the ambulatory potential of lower limb amputees with and without the use of a prosthesis. It assesses the mobility of people with lower limb amputation prior to prosthetic fitting and predicts function following prosthetic prescription.
Time frame: Lab visit prior to start of home trial and lab visit upon completion of 4 week trial with each device